These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25534698)

  • 1. Pulmonary drug delivery by surfactant.
    Tsao PN
    Pediatr Neonatol; 2015 Feb; 56(1):3-4. PubMed ID: 25534698
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of surfactant and budesonide on the pulmonary distribution of fluorescent dye in mice.
    Huang LT; Yeh TF; Kuo YL; Chen PC; Chen CM
    Pediatr Neonatol; 2015 Feb; 56(1):19-24. PubMed ID: 25199848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2018 Jan; 247():80-86. PubMed ID: 28963086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits.
    Fajardo C; Levin D; Garcia M; Abrams D; Adamson I
    Pediatr Res; 1998 Apr; 43(4 Pt 1):542-7. PubMed ID: 9545012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids.
    Cimato A; Hoyos Obando A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2016 Nov; 233():33-40. PubMed ID: 27476933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
    Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
    J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
    Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
    J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of budesonide on TGF-beta1-enhanced VEGF production by lung fibroblasts.
    Chen YJ; Wang T; Liu DS; Xu D; Chen L; An J; Wen FQ
    Cell Biol Int; 2010 Jul; 34(7):777-82. PubMed ID: 20359293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities for use of phospholipid nanosystem with glycyrrhizic acid ("phosphogliv") for optimization of drugs: doxorubicin and budesonide as examples].
    Ipatova OM; Zykova MG; Prozorovskiĭ VN; Torkhovskaia TI; Zakharova TS
    Biomed Khim; 2009; 55(2):185-94. PubMed ID: 19507342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma, steroids, and growth.
    Wohl ME; Majzoub JA
    N Engl J Med; 2000 Oct; 343(15):1113-4. PubMed ID: 11027747
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroids use in pediatric cardiac surgery: more questions.
    Brunow de Carvalho W; Fonseca MC
    Pediatr Crit Care Med; 2007 Sep; 8(5):503-4. PubMed ID: 17873789
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol.
    Todorova L; Gürcan E; Miller-Larsson A; Westergren-Thorsson G
    Am J Respir Cell Mol Biol; 2006 Jan; 34(1):92-100. PubMed ID: 16166747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled glucocorticoids and adult height.
    Hughes-Davies T
    N Engl J Med; 2012 Nov; 367(22):2156; author reply 2156-7. PubMed ID: 23190233
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of budesonide on chronic airway inflammation in guinea pigs sensitized with repeated exposure to allergen].
    Xiang L; Guo DY; Jiang ZF; Liu SY; Xiong ZY
    Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):414-7. PubMed ID: 16053723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of nebulised budesonide (Pulmicort Respules) and beclomethasone dipropionate (Clenil per Aerosol).
    Vaghi A; Berg E; Liljedahl S; Svensson JO
    Pulm Pharmacol Ther; 2005; 18(2):151-3. PubMed ID: 15649857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery system for budesonide based on lipid-DNA.
    Liu Y; Bos IST; Oenema TA; Meurs H; Maarsingh H; Hirsch AKH
    Eur J Pharm Biopharm; 2018 Sep; 130():123-127. PubMed ID: 29908939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma.
    Pelaia G; Vatrella A; Busceti MT; Fabiano F; Terracciano R; Matera MG; Maselli R
    Pulm Pharmacol Ther; 2016 Oct; 40():15-21. PubMed ID: 27381656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
    Lindmark B
    Ther Adv Respir Dis; 2008 Oct; 2(5):279-99. PubMed ID: 19124378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
    Adner M; Larsson B; Säfholm J; Naya I; Miller-Larsson A
    J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.